EP2992017
Mótefni sem er beint gegn stýrðum dauða-1 (PD-1)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.5.2014EP published:
18.11.2020EP application number:
14791454.3
EP translation filed:
26.1.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
1.5.2034Expiry date:
1.5.2026Next due date:
31.5.2026
Title:
ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 (PD-1)
Timeline
Today
2.5.2014EP application
18.11.2020EP Publication
26.1.2021Translation submitted
15.2.2021Registration published
1.5.2026Expires
Owner
Name:
AnaptysBio, Inc.Address:
10770 Wateridge Circle, Suite 210, San Diego, CA 92121, US
Inventor
Name:
KING, David J.Address:
Encinitas, California 92024, US
Name:
KEHRY, MarilynAddress:
San Diego, California 92131, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361818755 PDate:
2.5.2013Country:
US
Supplementary protection
SPC number:
SPC348
Classification
Categories:
C07K 16/28, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 21.4.2021
Expires: 1.5.2022
Payer: Patice ehf.
Number: 9
Paid: 19.4.2022
Expires: 1.5.2023
Payer: Patice ehf.
Number: 10
Paid: 22.4.2023
Expires: 1.5.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 19.4.2024
Expires: 1.5.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.5.2025
Expires: 1.5.2026
Payer: Árnason Faktor ehf.